McKesson Ventures, the San Francisco CA-based venture capital arm of McKesson Corporation, appointed Dave Schulte as managing director, effective September 8, 2015.
Schulte joins McKesson from Kaiser Permanente Ventures where he served as vice president and managing director.
He has more than 17 years of experience as an investor and investment banker, partnering with entrepreneurs to grow innovative health care and technology businesses. Schulte joined Kaiser Permanente Ventures in 2003 and helped build the investment program from $20M to $400M of assets under management.
Prior to KP Ventures, he was a software and health care investment banker at J.P. Morgan (Hambrecht & Quist), UBS, and Piper Jaffray.
In his role at McKesson, Schulte will be responsible for co-leading the development and management of the McKesson Ventures portfolio alongside group leader Tom Rodgers.
Established in December 2014 and led by Tom Rodgers, senior vice president and managing director, McKesson Ventures targets companies that are both enabling and benefitting from disruptive changes affecting the health care industry, including increasing consumerism, emergence of alternate delivery models and the shift towards value based care.
To date, it has made minority investments in:
– Carena, a telemedicine provider;
– Accolade, a concierge health care navigation and employee health engagement platform;
– PipelineRx, a technology and services platform company focused on telepharmacy, and
– Rock Health’s seed fund, among others.